Inventor
VOGTLI KURT
CH7 patents
⚠️ This page may combine multiple inventors who share the name “VOGTLI KURT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AICURIS ANTI INFECTIVE CURES GMBH
3 patentsUS10137117B2Nov 27, 2018
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH6 citations81
US9889124B2Feb 13, 2018
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH6 citations81
USRE49697EOct 17, 2023
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH0 citations60
AICURIS GMBH & CO KG
2 patentsUS9119786B2Sep 1, 2015
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS GMBH & CO KG15 citations90
US9340535B2May 17, 2016
N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
AICURIS GMBH & CO KG5 citations71